Sep 05, 2018 5:30am EDT Achieve to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018
Aug 08, 2018 4:05pm EDT Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update
Aug 02, 2018 5:30am EDT Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018
Jul 11, 2018 5:30am EDT Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA
Jun 26, 2018 5:30am EDT Achieve Announces Positive Cytisine Data Demonstrating No Clinically Significant Drug-Drug Interaction
Jun 19, 2018 4:01pm EDT Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Jun 15, 2018 8:30am EDT Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
Jun 11, 2018 5:30am EDT Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules